Lazard Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-41,037
| Closed | -$551K | – | 2619 |
|
|
2023
Q1 | $551K | Hold |
41,037
| – | – | ﹤0.01% | 1094 |
|
|
2022
Q4 | $507K | Sell |
41,037
-16,158
| -28% | -$200K | ﹤0.01% | 1121 |
|
|
2022
Q3 | $797K | Buy |
57,195
+35,753
| +167% | +$498K | ﹤0.01% | 1021 |
|
|
2022
Q2 | $296K | Sell |
21,442
-40,173
| -65% | -$555K | ﹤0.01% | 1204 |
|
|
2022
Q1 | $1M | Buy |
61,615
+19,194
| +45% | +$312K | ﹤0.01% | 996 |
|
|
2021
Q4 | $691K | Buy |
+42,421
| New | +$691K | ﹤0.01% | 1056 |
|
|
2021
Q1 | – | Sell |
-7,653
| Closed | -$189K | – | 2078 |
|
|
2020
Q4 | $189K | Buy |
7,653
+7,004
| +1,079% | +$173K | ﹤0.01% | 1107 |
|
|
2020
Q3 | $26K | Sell |
649
-6,146
| -90% | -$246K | ﹤0.01% | 1371 |
|
|
2020
Q2 | $325K | Buy |
6,795
+5,439
| +401% | +$260K | ﹤0.01% | 866 |
|
|
2020
Q1 | $85K | Buy |
+1,356
| New | +$85K | ﹤0.01% | 1035 |
|